Market Overview

Benchmark Company Reiterates Buy Rating, $87 PT on Analogic Corporation

Related ALOG
Zacks Rank #5 Additions for Tuesday - Tale of the Tape
Analogic Announces Agreement to Distribute Prostate Guidance Solution

In a report published Wednesday, Benchmark Company reiterated its Buy rating and $87.00 price target on Analogic Corporation (NASDAQ: ALOG).

Benchmark Company noted, “We believe that there is the opportunity for expense reductions in general and administrative expenses. We also believe, to a smaller degree that there is an opportunity for expense reductions in both manufacturing expenses and in research and development expenses. We do not believe that ALOG will focus on expense reductions within sales and marketing as the larger distribution channel is a driver in this transaction. Ultrasonix is a profitable company and while we believe that ALOG made the acquisition to gain the expanded product line and the expanded distribution channel, we also believe that over time, ALOG will be able to reduce expenses where there is overlap. We believe Ultrasonix had approximately 130 employees.”

Analogic Corporation closed on Tuesday at $74.60.

Posted-In: Benchmark CompanyAnalyst Color Reiteration Analyst Ratings

 

Most Popular

Related Articles (ALOG)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free